Loading chat...
IN HR0063
Resolution
Status
4/11/2017
Primary Sponsor
Steven Davisson
Click for details
AI Summary
-
Urges the legislative council to assign a study committee to examine commercial insurance coverage of FDA-approved abuse deterrent opioid analgesics when prescribed by providers to benefit patients or prevent diversion and abuse
-
Requires the study committee to also examine commercial insurer coverage of inpatient detoxification services and FDA-approved medication-assisted treatments
-
Cites drug overdose deaths as an ongoing public health crisis in Indiana as justification for the study
Legislative Description
Urging the legislative council to assign to the appropriate study committee the topic of the coverage of Federal Drug Administration approved abuse deterrent opioid analgesics by commercial insurance when providers determine that the prescription would be in the best interest of the patient or would prevent diversion or abuse of an opioid-based medication
Last Action
First reading: adopted voice vote
4/11/2017